Sangamo backs up early success for hemophilia gene therapy
Προς έγκριση 8 νέες θεραπείες στην Ε.Ε.
Gene therapy: how much will it cost patients?
Top 25 Biotech Companies of 2018
As gene therapy gains traction, it is expected to create a number of job opportunities. For example, the UK government projects gene and cell therapy in Britain alone will create 18,000 new … Continue Reading Gene Therapy, Gene Editing and Immuno-Oncology Creating Thousands of New Job Opportunities
Miracles, it seems, have a high price tag. At least, if those miracles are miracle drugs. There’s no doubt that trends in gene therapy and immuno-oncology are producing drugs that … Continue Reading A Look at Hemophilia Drug Prices and the Market
BioMarin Pharmaceutical received $20 million in milestone payments from Pfizer after the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) approved its applications for talazoparib. Talazoparib is a … Continue Reading Pfizer Pays BioMarin Pharma $20 Million Milestone